MYELOID NEOPLASIA Advancing the STATus of MPN pathogenesis

被引:2
作者
Shah, Neil P. [1 ]
Shannon, Kevin [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
TRANSFORMATION; LEUKEMIA; BCR/ABL;
D O I
10.1182/blood-2012-02-406611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3374 / 3376
页数:5
相关论文
共 15 条
[1]   Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation [J].
Cui, Y ;
Riedlinger, G ;
Miyoshi, K ;
Tang, W ;
Li, CL ;
Deng, CX ;
Robinson, GW ;
Hennighausen, L .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (18) :8037-8047
[2]   The role of Stat5 transcription factors as tumor suppressors or oncogenes [J].
Ferbeyre, G. ;
Moriggl, R. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1815 (01) :104-114
[3]  
Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]
[4]   Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation [J].
Hoelbl, Andrea ;
Kovacic, Boris ;
Kerenyi, Marc A. ;
Simma, Olivia ;
Warsch, Wolfgang ;
Cui, Yongzhi ;
Beug, Hartmut ;
Hennighausen, Lothar ;
Moriggl, Richard ;
Sexl, Veronika .
BLOOD, 2006, 107 (12) :4898-4906
[5]   Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia [J].
Hoelbl, Andrea ;
Schuster, Christian ;
Kovacic, Boris ;
Zhu, Bingmei ;
Wickre, Mark ;
Hoelzl, Maria A. ;
Fajmann, Sabine ;
Grebien, Florian ;
Warsch, Wolfgang ;
Stengl, Gabriele ;
Hennighausen, Lothar ;
Poli, Valeria ;
Beug, Hartmut ;
Moriggl, Richard ;
Sexl, Veronika .
EMBO MOLECULAR MEDICINE, 2010, 2 (03) :98-110
[6]   INDUCIBLE GENE TARGETING IN MICE [J].
KUHN, R ;
SCHWENK, F ;
AGUET, M ;
RAJEWSKY, K .
SCIENCE, 1995, 269 (5229) :1427-1429
[7]   A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice [J].
Lyubynska, Natalya ;
Gorman, Matthew F. ;
Lauchle, Jennifer O. ;
Hong, Wan Xing ;
Akutagawa, Jon K. ;
Shannon, Kevin ;
Braun, Benjamin S. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (76)
[8]   The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors [J].
Nelson, Erik A. ;
Walker, Sarah R. ;
Weisberg, Ellen ;
Bar-Natan, Michal ;
Barrett, Rosemary ;
Gashin, Laurie B. ;
Terrell, Shariya ;
Klitgaard, Josephine L. ;
Santo, Loredana ;
Addorio, Martha R. ;
Ebert, Benjamin L. ;
Griffin, James D. ;
Frank, David A. .
BLOOD, 2011, 117 (12) :3421-3429
[9]   Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway [J].
Okutani, Y ;
Kitanaka, A ;
Tanaka, T ;
Kamano, H ;
Ohnishi, H ;
Kubota, Y ;
Ishida, T ;
Takahara, J .
ONCOGENE, 2001, 20 (45) :6643-6650
[10]   Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis [J].
Pardanani, Animesh ;
Gotlib, Jason R. ;
Jamieson, Catriona ;
Cortes, Jorge E. ;
Talpaz, Moshe ;
Stone, Richard M. ;
Silverman, Michael H. ;
Gilliland, D. Gary ;
Shorr, Jolene ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) :789-796